VRCA
Verrica Pharmaceuticals Inc
NASDAQ: VRCA · HEALTHCARE · BIOTECHNOLOGY
$6.37
-3.19% today
Updated 2026-04-30
Market cap
$112.18M
P/E ratio
—
P/S ratio
3.15x
EPS (TTM)
$-1.68
Dividend yield
—
52W range
$3 – $10
Volume
0.1M
Verrica Pharmaceuticals Inc (VRCA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-50.30%
Operating margin
-136.40%
ROE
-240.40%
ROA
-14.70%
Debt/equity
-2.10x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $0.00 | $-1.91M | — | — | — |
| 2017 | $0.00 | $-4.46M | — | — | — |
| 2018 | $0.00 | $-20.65M | — | — | — |
| 2019 | $0.00 | $-27.95M | — | — | — |
| 2020 | $12.00M | $-45.50M | -1.91% | -334.84% | -379.14% |
| 2021 | $12.00M | $-35.08M | 96.07% | -257.57% | -292.33% |
| 2022 | $9.03M | $-24.49M | 91.97% | -235.78% | -271.11% |
| 2023 | $5.12M | $-67.00M | 85.44% | -1,283.35% | -1,307.47% |
| 2024 | $7.57M | $-76.58M | 63.79% | -871.25% | -1,012.15% |
| 2025 | $35.58M | $-17.89M | 90.33% | -33.56% | -50.27% |